Replies to post #240745 on Biotech Values

[LongRun8]

Re HBV injectable drugs

I’m skeptical of HBV regimens containing a costly, infused agent such as Opdivo.

I agree. The bar has been set high with current HCV treatments (i.e. all-oral drug regimens).